Keywords: UK, NICE, Sanofi-Aventis, Multaq, Atrial fibrillation

Good news for Sanofi-Aventis as UK’s NICE recommends Multaq for AF

Article | 30 March 2010

Print This

There was some positive news for French drug major Sanofi-Aventis late yesterday, when the UK’s National Institute for Health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in